Tech Made Simple

Hot Topics: How to Fix Bluetooth Problems | The Best Holiday Gifts | Best Fitness Trackers Under $50 | Complete Guide to Facebook Privacy

Top News Stories

author photo

FDA Approves First Ever 3D Printed Drug

by on August 06, 2015
in Health & Fitness, News, Health and Home, Printers & Scanners, Blog :: 0 comments

3D printed pillBig news in the field of medicine: The U.S. Food and Drug Administration (FDA) has just approved a new drug from Aprecia Pharmaceuticals called Spritam (levetiracetam). It’s an epilepsy treatment manufactured by a 3D printer – the first ever 3D-printed pill to gain FDA approval.

3D printing is absolutely integral to how the drug is delivered to the body. Because seizure sufferers have difficulty swallowing, this particular pill is designed to quickly dissolve in the mouth. Its 3D-printed nature also guarantees that the pill is uniform, allowing it to be customized for more exacting doses.

“By combining 3-D printing technology with a highly-prescribed epilepsy treatment, SPRITAM is designed to fill a need for patients who struggle with their current medication experience,” explains Aprecia CEO Don Wetherhold. “This is the first in a line of central nervous system products Aprecia plans to introduce as part of our commitment to transform the way patients experience taking medication.”

While most 3D printers found in retail stores are mainly for hobbyist applications, industrial 3D printers are doing some pretty impressive things. There are already 3D printers for human body parts, chocolate designs and motor vehicles. There have even been attempts to share plans for a 3D-printed gun, though it has suffered significant legal roadblocks along the way.

It is expected that Spritam will be available sometime in the first quarter of 2016. For more information, visit the Aprecia Pharmaceuticals website.

[Image credit: Aprecia]



Discussion loading

© 2015 Techlicious LLC. Home | About | Meet the Team | Sponsorship Opportunities | Newsletter Archive | Contact Us | Terms of Use | Privacy Policy

site design: Juxtaprose